BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 3475452)

  • 1. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    Kendall DA; Taylor DP; Enna SJ
    Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
    Kung MP; Chumpradit S; Billings J; Kung H
    Life Sci; 1992; 51(2):95-106. PubMed ID: 1614281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
    Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
    Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The existence on the serotonin carrier of 2 independent sites for the specific binding of trazodone and imizin].
    Katanasov AB; Brusov OS
    Farmakol Toksikol; 1988; 51(6):32-5. PubMed ID: 2976683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral cocaine receptors.
    Calligaro DO; Eldefrawi ME
    J Pharmacol Exp Ther; 1987 Oct; 243(1):61-8. PubMed ID: 2822906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes.
    Hamblin MW; Adriaenssens PI; Ariani K; Cawthon RM; Stratford CA; Tan GL; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Mar; 240(3):701-11. PubMed ID: 3559968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
    Kovachich GB; Aronson CE; Brunswick DJ; Frazer A
    Brain Res; 1988 Jun; 454(1-2):78-88. PubMed ID: 2970277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
    Wolfe J; Kreider MS; Goodman C; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):196-203. PubMed ID: 3572782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.